Goodwill and Other Intangible Assets (Tables)

3 Months Ended

Apr. 01, 2012

Schedule of Goodwill

The components and changes in the carrying amount of goodwill follow:

(millions of dollars)	Primary Care			Specialty Care and Oncology			Established Products and Emerging Markets			Animal Health and Consumer Healthcare			Nutrition		Total
Balance, December 31, 2011	$	6,229		$	17,097		$	18,746		$	2,497		$	498	$	45,067
Additions(a)		—			—			—			361			—		361
Other(b)		(24	)		(66	)		(73	)		(17	)		4		(176	)
Balance, April 1, 2012	$	6,205		$	17,031		$	18,673		$	2,841		$	502	$	45,252

(a)	Related to our acquisitions of Alacer and Ferrosan, see Note 2A. Acquisitions and Divestitures: Acquisitions.
(b)	Primarily reflects the impact of foreign exchange.

Schedule of Finite Lived And Indefinite Lived Intangible Assets

The components of identifiable intangible assets follow:

	April 1, 2012							December 31, 2011
(millions of dollars)	Gross Carrying Amount		Accumulated Amortization			Identifiable Intangible Assets, less Accumulated Amortization		Gross Carrying Amount		Accumulated Amortization			Identifiable Intangible Assets, less Accumulated Amortization
Finite-lived intangible assets:
Developed technology rights	$	73,127	$	(33,447	)	$	39,680	$	73,088	$	(32,013	)	$	41,075
Brands		1,938		(709	)		1,229		1,678		(687	)		991
License agreements		440		(246	)		194		425		(215	)		210
Other		651		(398	)		253		623		(362	)		261
Total finite-lived intangible assets		76,156		(34,800	)		41,356		75,814		(33,277	)		42,537
Indefinite-lived intangible assets:
Brands		10,480		—			10,480		10,027		—			10,027
In-process research and development		892		—			892		1,197		—			1,197
Trademarks		73		—			73		72		—			72
Total indefinite-lived intangible assets		11,445		—			11,445		11,296		—			11,296
Total identifiable intangible assets(a)	$	87,601	$	(34,800	)	$	52,801	$	87,110	$	(33,277	)	$	53,833

(a) The decrease is primarily related to amortization, as well as impairment charges (see Note 4. Other Deductions—Net), partially offset by the assets acquired as part of the acquisitions of Ferrosan and Alacer (see Note 2A. Acquisitions and Divestitures: Acquisitions) and the impact of foreign exchange.